'historic' herbs mentioned in the paper are routinely dispensed by the local pharmacy, e.g. Filipendula ulmaria (meadowsweet), Glycyrrhiza glabra (liquorice). Patients referred to the medical herbalist are prescribed an alcohol-based tincture comprising 1-6 different species. The whole plant is used in such preparations, and not an isolated extract of an individual compound as would be the case in the preparation of a plant-derived drug within the pharmaceutical industry. The materia medica comprises about 150 different herbs, mainly dispensed as tinctures but some as topical preparations. These forms of prescriptions clearly distinguish European herbal medicine from homoeopathy and Chinese herbal medicine whose clinical practices and materia medica are entirely different. There is much media confusion regarding these three 'alternative' therapies.
We have found that certain conditions respond better to herbal medicine than to orthodox drugs e.g. irritable bowel syndrome and other gastrointestinal disorders, the treatment of which has become a special interest of the medical herbalist at this centre. Some of the herbs' unique properties (not mirrored by any allopathic alternatives) allow safe effective relief from symptoms which cannot be controlled by standard preparations.
The information derived from modern biochemical analyses of medicinal plants allows the historic uses to be fully appreciated and understood on a sound scientific basis. Thus today's medical herbalist can achieve excellent results by drawing upon the latest research as well as on a wealth of historical data. (December 1996 JRSM pp681-7) elegantly demonstrate the reduced use of central inpatient services associated with the availability of community hospital beds. However, I was surprised to find no reference to work I published with colleagues in 1994 recording a decrease in cancer deaths in central specialist inpatient beds (district general hospital) where community hospital beds were available to general practitioners.1 Our data, collected in an analogous situation in Exeter and East Devon, revealed that the place of death for patients with access to community hospital beds was as follows: home 29%; community hospital 39%; DGH 17%; nursing or residential home or hospice 14%. For patients without access to community hospital beds the place of death was home 41%, DGH 39%, nursing or residential homes and hospice 20%.
The presence of community hospital beds was associated with a significant reduction of deaths in the DGH (P<0.001) and with a greater number of patients receiving terminal care under their own general practitioner (74% of cases with community hospital beds versus 51% of cases without community hospital beds, P<0.001). By extrapolation to the rest of the UK we estimated that around 8% of all cancer patients might be dying in community hospital beds, a figure approaching that occurring in inpatient hospice beds.2
Hine and colleagues are right to state that community hospitals are one option for providing accessible (and appropriate) care and merit systematic evaluation of costs and benefits. This is one of the stated aims of the Community Hospitals Association (CHA), and I would encourage researchers to communicate details ofwork in progress or completed to me in my role as CHA committee member with an interest in related research.
David Seamark
The characterized by a high ESR, is one of the greatest emergencies in general medical practice. A quick estimation of ESR is required in any patient around age 60 who complains of intractable headache, particularly occipital and temporal, pain in the face, jaw and mouth exacerbated by chewing, with tenderness over the scalp and over the temporal and cranial arteries. In such a case steroid treatment must be started immediately, and the patient should not leave until the ESR is known. In less obvious cases steroids may reasonably be withheld pending the result of an ESR done on the spot, but not for the time taken by a routine hospital laboratory to measure viscosity. The ESR, simple to estimate, is ideal for the doctor's surgery, for the district hospital's outpatient clinic, and for use at the bedside. A delay of even a few hours in starting steroid therapy may result in irreversible visual failure'. Further, an elderly patient presenting with sudden loss of vision in one or both eyes requires an immediate intravenous injection of 10 mg dexamethazone before the ESR or plasma viscosity result is known'. Anthony Freeman Meadow Rise, 3 Lakeside, Swindon SN3 1QU, England REFERENCE 1 Freeman AG. The diagnosis and management of arteritis. J R Soc Med 1994; 87:248 Sailors, scurvy and science Dr Thomas (January 1997 JRSM, pp 50-54) has appropriately addressed the interesting subject of controlled clinical trials in medical history. In the context of vaccination, he cites the 'beautifully reasoned and critically observed trials' conducted by Edward Jenner. In fact (although they had significant methodological problems), it was William Woodville (1752 Woodville ( -1805 and George Pearson FRS (1751-1828) of the St Pancras Smallpox Hospital who established beyond doubt the efficacy of vaccination in a large clinical study carried out in the vicinity of their hospital'. These pioneers recorded 814 deaths from smallpox during a 20-year period (1799-1818) at their hospital and 22480 in the local parishes; these figures were compared with 'historical' controls over a period of a similar length (1779) (1780) (1781) (1782) (1783) (1784) (1785) (1786) (1787) (1788) (1789) (1790) (1791) (1792) (1793) (1794) (1795) (1796) (1797) (1798) before the introduction of vaccination when mortality figures were 1867 and 36 189, respectively; thus, vaccination resulted in a reduction in mortality of 1053 according to the hospital register, and 13 709 in the parish register.
An 'historical' control group would not be acceptable today, but this is probably the largest clinical trial undertaken (and subsequently published) in early medical history. G 
